GASTROINTESTINAL CANCER
Robert J. Mayer, MD
Dana-Farber Cancer Institute
Improved treatment approaches to colon and rectal cancer, and to pancreatic cancer
Acceptance Speech
    Robert J. Mayer, MD, is director of the Center for Gastrointestinal Oncology and vice president for academic affairs in the Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI). He currently serves as faculty vice president for Academic Affairs at DFCI and faculty associate dean for admissions at Harvard Medical School. His work and accomplishments include:
    • Co-leader of the Gastrointestinal Malignancies program at the Dana-Farber/Harvard Cancer Center, specifically the Gastrointestinal Cancer Committee for the Cancer and Leukemia Group B—a multiinstitutional collaboration supported by the National Cancer Institute
    • Defined optimal postsurgical treatment for colon and rectal cancer, and identified newer approaches to localized and advanced pancreatic cancer
    • Led research efforts to develop cetuximab for colorectal tumors that express the epidermal growth factor receptor
    • Served as program director for the Medical Oncology Fellowship Program at DFCI for more than 20 years, and has been responsible for the education of more than 200 trainees, many of whom have assumed major leadership roles throughout the United States
    • Past president of the American Society of Clinical Oncology
Program Information:
Nominate
Sponsor
News
Previous Inductees:
2013 | 2014
2015 | 2016
2017 | 2018
Connect: